When you share your genetic data – even with the NHS – you don’t know where it will end up, or how it will be used.
Articles on 23andMe
Displaying 21 - 28 of 28 articles
Researchers find 351 genetic variants associated with a person’s chronotype. Before this study, we knew of only 24.
Alzheimer’s is not only the third leading cause of death in the U.S. but also the most dreaded diagnosis. Genetic testing can help determine susceptibility, but knowing whether to test isn’t easy.
Data and privacy issues are tangled up in the DNA reports consumers get from big genetic testing companies – and the third-party sites they turn to in order to glean more from their raw DNA.
More people are sending off saliva samples to find out about their genetic roots. But the raw DNA results go way beyond genealogical data – and could deliver unintended consequences.
A genetics testing company recently won approval from the FDA to market a test that can identify a breast cancer gene mutation. But what are women supposed to do with that information? There’s risk involved.
The market for personal genome services is facing a reality check. While the most prominent and innovative company 23andMe has flourished so far, in the past few years many of its competitors have gone…
Genetic testing is a powerful tool. Two years ago, with the help of my colleagues, it was this tool that helped us identify a new disease. The disease, called Ogden Syndrome, caused the death of a four-month…
Top contributors
-
Professor of English, York University, Canada
-
PhD Candidate in Law, Queen's University, Ontario
-
Research Scientist in Biostatistics, University of Washington
-
Assistant Professor in Human Genetics, Cold Spring Harbor Laboratory
-
Associate Professor of Anthropology, University of California, Davis
-
Professor of Law, George Washington University
-
Associate Professor of Community Health Sciences, Boston University
-
Ethical, Legal & Social Adviser in Public Health Genomics, Monash University
-
Associate Professor of Population and Statistical Genetics, Hebrew University of Jerusalem
-
Françoise Clerget-Darpoux is a Friend of The Conversation.
Directeur de recherches émérite en génétique statistique, Inserm
-
PhD Candidate, School of Law, Trinity College Dublin
-
Professor of Law, University of Virginia
-
Research Fellow, University of Exeter
-
Academic Fellow, University of Sydney Law School, University of Sydney
-
Professor of Health Law, Public Health Law and Medical Ethics, University of South Florida